Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:19 AM
Ignite Modification Date:
2025-12-25 @ 4:19 AM
NCT ID:
NCT02610920
Eligibility Criteria:
Inclusion Criteria:
* Female patients at least 21 years old
* Patients with invasive ductal carcinoma staged T1 or T2 with estrogen receptor and progesterone receptor positive (ER+/PR+) who are scheduled for sentinel lymph node biopsy
* Patients with Ductal Carcinoma In Situ (DCIS) (high or low grade) who are scheduled for sentinel lymph node biopsy including:
* Patients having a mastectomy
* Patients with palpable DCIS
* Patients undergoing breast conservation with large (\>5cm) area of DCIS
* Patients with signed consent to participate
Exclusion Criteria:
* Preoperative palpable axillary lymphadenopathy
* Preoperative ultrasound demonstrating suspicious adenopathy
* Previous axillary dissection or previous lymph node biopsy
* Patients with Invasive Lobular Carcinoma
* Patients who are pregnant
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Study:
NCT02610920
Study Brief:
Protocol Section:
NCT02610920